{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:15:39Z","timestamp":1792224939624,"version":"4.4.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,11]]},"abstract":"<jats:p>Several disorders of coagulation and fibrinolysis have been widely reported in patients with hyperthyroidism. Most reports have focused on only the venous thromboembolism risk, and few of them have studied specifically the association between hyperthyroidism and pulmonary embolism (PE). We report two cases of Graves\u2019 disease complicated by PE. The first patient is a 32 year-old man, and the second patient is a 23-year-old female. PE was suspected on the basis of pulmonary hypertension in patient one, and clinical presentation in the other patient. The first patient had also right heart failure. PE was confirmed in both patients by a lung perfusion-ventilation scan test. Thrombophilia screen revealed normal findings in the first patient and an elevation in coagulation factor VIII in the second one. Both patients received heparin, followed by oral anticoagulant therapy. In addition, they were treated with radioactive iodine resulting in partial recovery from hyperthyroidismforpatient oneand clinical euthyroidism for patient two. The former died of acute heart failure secondary to a chest infection, while the later was lost to follow-up. In conclusion, hyperthyroidism is associated with increased risk of venous thromboembolism, including PE. Potential mechanisms involved in this association include endothelial dysfunction, decreased fibrinolytic activity, and increased coagulation factors levels. Thyroid evaluation is recommended in patients with unprovoked venous thromboembolic events. Conversely, the diagnosis of venous thromboembolism should be considered in patients with hyperthyroidism, particularly if additional prothrombotic risk factors are present.<\/jats:p>","DOI":"10.4103\/2230-8210.122640","type":"journal-article","created":{"date-parts":[[2013,12,3]],"date-time":"2013-12-03T03:26:31Z","timestamp":1386041191000},"page":"1104-1107","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Hyperthyroidism: A rare cause of pulmonary embolism: Report of two cases"],"prefix":"10.4103","volume":"17","author":[{"given":"Sonia","family":"Grine","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Hedi Chaker Hospital, 3029 Sfax, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Charfi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hedi Chaker Hospital, 3029 Sfax, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Kamoun","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hedi Chaker Hospital, 3029 Sfax, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Mnif","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hedi Chaker Hospital, 3029 Sfax, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basma Ben","family":"Naceur","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hedi Chaker Hospital, 3029 Sfax, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabila","family":"Rekik","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hedi Chaker Hospital, 3029 Sfax, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouna","family":"Mnif","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hedi Chaker Hospital, 3029 Sfax, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abid","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hedi Chaker Hospital, 3029 Sfax, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260327","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1515\/CCLM.2010.371","article-title":"Hypercoagulable state, pathophysiology, classification and epidemiology","volume":"48","author":"Alfirevi\u0107","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"R2-20260327","doi-asserted-by":"crossref","first-page":"I4","DOI":"10.1161\/01.CIR.0000078468.11849.66","article-title":"The epidemiology of venous thromboembolism","volume":"107","author":"White","year":"2003","journal-title":"Circulation"},{"key":"R3-20260327","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-0030-1270067","article-title":"Thyroid disorders and hypercoagulability","volume":"37","author":"Erem","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"R4-20260327","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s12020-009-9185-z","article-title":"Coagulation and fibrinolysis in thyroid dysfunction","volume":"36","author":"Erem","year":"2009","journal-title":"Endocrine"},{"key":"R5-20260327","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1210\/jc.2007-0199","article-title":"Clinical review: Thyroid dysfunction and effects on coagulation and fibrinolysis: A systematic review","volume":"92","author":"Squizzato","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-20260327","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0030-1270065","article-title":"The spectrum of coagulation abnormalities in thyroid disorders","volume":"37","author":"Vescovi","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"R7-20260327","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1111\/j.1538-7836.2010.03993.x","article-title":"Increased risk of pulmonary embolism among patients with hyperthyroidism: Afive-year follow-up study","volume":"8","author":"Lin","year":"2010","journal-title":"J Thromb Haemost"},{"key":"R8-20260327","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s00392-006-0395-6","article-title":"Emergency coronary angiography with gadolinium in a patient with thyrotoxicosis, pulmonary embolism and persistent right atrial thrombi","volume":"95","author":"Werner","year":"2006","journal-title":"Clin Res Cardiol"},{"key":"R9-20260327","first-page":"53","article-title":"Possible association of venous thromboembolism and hyperthyroidism: Fourcase reports and literature review","volume":"121","author":"Kim","year":"2008","journal-title":"NZ Med J"},{"key":"R10-20260327","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1177\/1076029609336856","article-title":"Venous throm boem bolism in patients hospitalized with thyroid dysfunction","volume":"15","author":"Danescu","year":"2009","journal-title":"Clin Appl Thromb Hemost"},{"key":"R11-20260327","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/1076029610364521","article-title":"Hyperthyroidism and venous thrombosis: A casual or causal association? A systematic literature review","volume":"17","author":"Franchini","year":"2011","journal-title":"Clin Appl Thromb Hemost"},{"key":"R12-20260327","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11239-006-5572-y","article-title":"The epidemiology of venous thromboembolism in the community: Implications for prevention and management","volume":"21","author":"Heit","year":"2006","journal-title":"J Thromb Thrombolysis"},{"key":"R13-20260327","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1159\/000083845","article-title":"Virchow's triad revisited: Abnormal flow","volume":"33","author":"Lowe","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"key":"R14-20260327","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF03344016","article-title":"Blood coagulation and fibrinolysis in patients with hyperthyroidism","volume":"25","author":"Erem","year":"2002","journal-title":"J Endocrinol Invest"},{"key":"R15-20260327","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1046\/j.1365-2362.1998.00381.x","article-title":"Impaired release of tissue plasminogen activator from the endothelium in Graves\u2019 diseaseindicator of endothelial dysfunction and reduced fibrinolytic capacity","volume":"28","author":"Li","year":"1998","journal-title":"Eur J Clin Invest"},{"key":"R16-20260327","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s11239-008-0269-z","article-title":"Hyperthyroidism is associated with shortened APTT and increased fibrinogen values in a general population of unselected outpatients","volume":"28","author":"Lippi","year":"2009","journal-title":"J Thromb Thrombolysis"},{"key":"R17-20260327","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1210\/jc.2005-1786","article-title":"Low serum thyrotropin is associated with high plasma fibrinogen","volume":"91","author":"D\u00f6rr","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R18-20260327","first-page":"CR42","article-title":"Levels of plasma fibrinogen and D-dimer in subjects with subclinical hyperthyroidism","volume":"14","author":"Coban","year":"2008","journal-title":"Med SciMonit"},{"key":"R19-20260327","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2265.2006.02464.x","article-title":"Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity","volume":"64","author":"Erem","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R20-20260327","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/jnnp.73.4.458","article-title":"Hyperthyroidism with increased factor VIII procoagulant protein as a predisposing factor for cerebral venous thrombosis","volume":"73","author":"Maes","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R21-20260327","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.2169\/internalmedicine.49.3429","article-title":"Cerebral venous thrombosis with elevated factor VIII","volume":"49","author":"Kanazawa","year":"2010","journal-title":"Intern Med"},{"key":"R22-20260327","first-page":"78","article-title":"Hyperthyroidism and cerebral venous thrombosis","volume":"54","author":"Mouton","year":"2005","journal-title":"EurNeurol"},{"key":"R23-20260327","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0037-1613747","article-title":"High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism","volume":"83","author":"Kraaijenhagen","year":"2000","journal-title":"Thromb Haemost"},{"key":"R24-20260327","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3122\/jabfm.18.2.147","article-title":"Excess factor VIII: A common cause of hypercoagulability","volume":"18","author":"Bobrow","year":"2005","journal-title":"J Am Board FamPract"},{"key":"R25-20260327","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1210\/jcem-63-2-407","article-title":"Effect of thyroid hormones on plasma protein concentrations inman","volume":"63","author":"Graninger","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"R26-20260327","first-page":"444","article-title":"Factor VIII activity in normal volunteers receiving oral thyroid hormone","volume":"102","author":"Rogers","year":"1983","journal-title":"J Lab Clin Med"},{"key":"R27-20260327","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/j.1538-7836.2011.04430.x","article-title":"Alterations in coagulation and fibrinolysis after levothyroxine exposure in healthy volunteers: A controlled randomized crossover study","volume":"9","author":"VAN Zaane","year":"2011","journal-title":"J ThrombHaemost"},{"key":"R28-20260327","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1182\/blood-2009-11-253724","article-title":"Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: a case-control study","volume":"115","author":"Van Zaane","year":"2010","journal-title":"Blood"},{"key":"R29-20260327","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.ijcard.2008.11.179","article-title":"Recurrent acute pulmonary embolism and paroxysmal atrial fibrillation associated with subclinical hyperthyroidism","volume":"142","author":"Patan\u00e8","year":"2010","journal-title":"Int J Cardiol"},{"key":"R30-20260327","first-page":"CR42","article-title":"Levels of plasma fibrinogen and D-dimer in subjects with subclinical hyperthyroidism","volume":"14","author":"Coban","year":"2008","journal-title":"Med SciMonit"}],"container-title":["Indian Journal of Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/02223308-201317060-00030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:38:14Z","timestamp":1786649894000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/02223308-201317060-00030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.4103\/2230-8210.122640","relation":{},"ISSN":["2230-8210","2230-9500"],"issn-type":[{"value":"2230-8210","type":"print"},{"value":"2230-9500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}